Cannabis use influences disorganized symptoms severity but not transition in a cohort of non-help-seeking individuals at-risk for psychosis from Sao Paulo, Brazil

Nenhuma Miniatura disponível
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2024
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
FEKIH-ROMDHANE, Feten
Citação
PSYCHIATRY RESEARCH, v.331, article ID 115665, 7p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Cannabis use is associated with an increased risk of developing a psychotic disorder. However, in individuals with at-risk mental states for psychosis (ARMS) this association is not clear, as well as the impact of cannabis use on symptom severity. The objective of this study was to evaluate the association of cannabis use patterns and ARMS risk status, transition to psychotic and psychiatric disorders, and psychopathology.Method: A sample of 109 ARMS and 197 control individuals was drawn from the general population. Lifetime, maximum and current amount of cannabis use were assessed with the South Westminster modified questionnaire. Participants were followed-up for a mean of 2.5 years and reassessed for transition to any psychiatric disorder. Results: There were no differences between ARMS and controls regarding lifetime use, current amount of use, or maximum amount of cannabis use. There were also no differences between those who transitioned to a psychiatric disorder and those who did not regarding cannabis use variables. In ARMS individuals, cannabis use was significantly related to disorganization symptoms.Conclusion: The results of this study suggest that cannabis plays a role in the psychopathology of ARMS individuals, leading to more severe symptomatology.
Palavras-chave
Schizophrenia, Disorganization, Subclinical psychosis
URI
https://observatorio.fm.usp.br/handle/OPI/58020
Referências
  1. Addington J, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-1027-y
  2. Auther AM, 2015, ACTA PSYCHIAT SCAND, V132, P60, DOI 10.1111/acps.12382
  3. Buchy L, 2014, SCHIZOPHR RES, V156, P277, DOI 10.1016/j.schres.2014.04.021
  4. Burns Jonathan K, 2013, Front Psychiatry, V4, P128, DOI 10.3389/fpsyt.2013.00128
  5. Carney R, 2017, ACTA PSYCHIAT SCAND, V136, P5, DOI 10.1111/acps.12699
  6. Casadio P, 2011, NEUROSCI BIOBEHAV R, V35, P1779, DOI 10.1016/j.neubiorev.2011.04.007
  7. Chapman C, 2017, J STUD ALCOHOL DRUGS, V78, P344, DOI 10.15288/jsad.2017.78.344
  8. Colizzi M, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9040093
  9. Cotter J, 2014, SCHIZOPHR RES, V159, P267, DOI 10.1016/j.schres.2014.09.012
  10. de Pablo GS, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01165-x
  11. Degenhardt L, 2013, ADDICTION, V108, P124, DOI 10.1111/j.1360-0443.2012.04015.x
  12. Diniz GN, 2021, BRAZ J PSYCHIAT, V43, P560, DOI 10.1590/1516-4446-2021-2056
  13. Donoghue K, 2014, PSYCHIAT RES, V215, P528, DOI 10.1016/j.psychres.2013.12.038
  14. Dragt S, 2012, ACTA PSYCHIAT SCAND, V125, P45, DOI 10.1111/j.1600-0447.2011.01763.x
  15. DUKE PJ, 1994, BRIT J PSYCHIAT, V164, P630, DOI 10.1192/bjp.164.5.630
  16. Farris MS, 2020, SOC PSYCH PSYCH EPID, V55, P527, DOI 10.1007/s00127-019-01810-x
  17. First M.B., 2017, Entrevista Clinica Estruturada Para OS Transtornos Do DSM-5:SCID-5-CV Versao Clinica
  18. First MB, 2016, Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCIDP), Version 2
  19. Freitas EL, 2020, INT J SOC PSYCHIATR, V66, P566, DOI 10.1177/0020764020922252
  20. Fusar-Poli P, 2016, JAMA PSYCHIAT, V73, P1260, DOI 10.1001/jamapsychiatry.2016.2707
  21. Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269
  22. Gonçalves Priscila Dib, 2012, J. bras. psiquiatr., V61, P96
  23. Helle S, 2016, SCHIZOPHR RES, V170, P217, DOI 10.1016/j.schres.2015.11.027
  24. Ising HK, 2012, SCHIZOPHRENIA BULL, V38, P1288, DOI 10.1093/schbul/sbs068
  25. Jones JD, 2017, J ADOLESCENT HEALTH, V60, P653, DOI 10.1016/j.jadohealth.2017.01.006
  26. Korver N, 2010, AUST NZ J PSYCHIAT, V44, P230, DOI 10.3109/00048670903487118
  27. Koskinen J, 2010, SCHIZOPHRENIA BULL, V36, P1115, DOI 10.1093/schbul/sbp031
  28. Kraan T, 2016, PSYCHOL MED, V46, P673, DOI 10.1017/S0033291715002329
  29. Kristensen K, 2007, PSYCHIAT RES, V151, P151, DOI 10.1016/j.psychres.2006.10.001
  30. Large M, 2011, ARCH GEN PSYCHIAT, V68, P555, DOI 10.1001/archgenpsychiatry.2011.5
  31. Lin A, 2015, AM J PSYCHIAT, V172, P249, DOI 10.1176/appi.ajp.2014.13030418
  32. Loch AA, 2022, PSYCHIAT RES, V307, DOI 10.1016/j.psychres.2021.114319
  33. Loch AA, 2022, NEUROSCI LETT, V770, DOI 10.1016/j.neulet.2021.136358
  34. Loch AA, 2019, SCHIZOPHR RES, V204, P353, DOI 10.1016/j.schres.2018.09.020
  35. Loch AA, 2017, PSYCHIAT RES, V253, P182, DOI 10.1016/j.psychres.2017.03.052
  36. Loewy RL, 2005, SCHIZOPHR RES, V77, P141, DOI 10.1016/j.schres.2005.03.007
  37. Marconi A, 2016, SCHIZOPHRENIA BULL, V42, P1262, DOI 10.1093/schbul/sbw003
  38. McDonald M, 2019, SCHIZOPHRENIA BULL, V45, P600, DOI 10.1093/schbul/sby069
  39. McGlashan TH., 2001, Structured Interview for Psychosis-risk Syndromes
  40. Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040
  41. Myles H, 2016, AUST NZ J PSYCHIAT, V50, P208, DOI 10.1177/0004867415599846
  42. Oliver D, 2020, SCHIZOPHRENIA BULL, V46, P110, DOI 10.1093/schbul/sbz039
  43. Phillips LJ, 2002, AUST NZ J PSYCHIAT, V36, P800, DOI 10.1046/j.1440-1614.2002.01089.x
  44. Rietdijk J, 2014, SOC PSYCH PSYCH EPID, V49, P349, DOI 10.1007/s00127-013-0772-1
  45. Schoeler T, 2016, LANCET PSYCHIAT, V3, P947, DOI 10.1016/S2215-0366(16)30188-2
  46. Schultze-Lutter F, 2010, SCHIZOPHRENIA BULL, V36, P182, DOI 10.1093/schbul/sbn072
  47. Seddon JL, 2016, SCHIZOPHRENIA BULL, V42, P619, DOI 10.1093/schbul/sbv154
  48. Solmi M, 2023, MOL PSYCHIATR, V28, P2291, DOI 10.1038/s41380-023-02029-8
  49. Svirskis T, 2005, SCHIZOPHR RES, V75, P439, DOI 10.1016/j.schres.2004.11.002
  50. Valmaggia LR, 2014, PSYCHOL MED, V44, P2503, DOI 10.1017/S0033291714000117
  51. van der Gaag M, 2013, SCHIZOPHR RES, V149, P56, DOI 10.1016/j.schres.2013.07.004
  52. van Os J, 2002, AM J EPIDEMIOL, V156, P319, DOI 10.1093/aje/kwf043
  53. Yung AR, 2015, PSYCHOL MED, V45, P3453, DOI 10.1017/S003329171500135X
  54. Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P283, DOI 10.1093/schbul/22.2.283

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - HC/IPer
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/27